Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 | 2026-09-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 6,018 | $50.35 | $303K | 38.0K | View | |
| 2026-09-17 | 2026-09-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sale | 5,000 | $50.35 | $252K | 25.0K | View | |
| 2026-08-17 | 2026-08-19 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 6,018 | $58.58 | $353K | 40.0K | View | |
| 2026-08-17 | 2026-08-19 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sale | 5,000 | $58.59 | $293K | 25.0K | View | |
| 2026-08-04 | 2026-08-06 | Derynck Mika K | Director | Sale | 158.8K | $60.21 | $9.56M | 0 | View |
Informational purposes only, not investment advice.
tormere.com/research/ELVN · generated 2026-10-05
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-17 | Hohl Benjamin | S | 3,535 | $176,851.1 |
| 2026-09-17 | Hohl Benjamin | S | 2,194 | $111,270.47 |
| 2026-09-17 | Hohl Benjamin | S | 289 | $14,881.45 |
| 2026-09-17 | Collins Helen Louise | S | 2,916 | $145,890.98 |
| 2026-09-17 | Collins Helen Louise | S | 1,844 | $93,507.21 |
Tormere — informational purposes only, not investment advice.